Published in J Invest Dermatol on February 01, 1993
Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo. Br J Dermatol (2015) 1.42
Topical tranexamic acid as a promising treatment for melasma. J Res Med Sci (2014) 1.42
Vitiligo--part 1. An Bras Dermatol (2014) 0.96
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients. Indian J Dermatol (2012) 0.88
Increased Tumor Necrosis Factor (TNF)-α and its promoter polymorphisms correlate with disease progression and higher susceptibility towards vitiligo. PLoS One (2012) 0.87
A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma. J Cutan Aesthet Surg (2013) 0.82
Tranexamic Acid Diminishes Laser-Induced Melanogenesis. Ann Dermatol (2015) 0.82
Analysis of inducible nitric oxide synthase gene polymorphisms in vitiligo in Han Chinese people. PLoS One (2011) 0.82
A clinical study on oral lichen planus with special emphasis on hyperpigmentation. J Pharm Bioallied Sci (2015) 0.79
Tumor necrosis factor B (TNFB) genetic variants and its increased expression are associated with vitiligo susceptibility. PLoS One (2013) 0.77
Parkinson's disease-associated melanin steal. Neuropsychiatr Dis Treat (2014) 0.76
Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets. BMC Genomics (2017) 0.75
The association between melasma and postinflammatory hyperpigmentation in acne patients. Iran Red Crescent Med J (2013) 0.75
Prevalence and subjective knowledge of tongue lesions in an Indian population. J Oral Biol Craniofac Res (2016) 0.75
Argon laser photoablation for postburn conjunctival pigmentation. Case Rep Med (2014) 0.75
Clinicopathological Profile and Malignant Transformation in Oral Lichen Planus: A Retrospective Study. J Int Soc Prev Community Dent (2017) 0.75
Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J Immunol (1982) 2.29
Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest (1984) 2.10
Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol (1990) 2.03
Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment. J Biol Chem (1988) 1.97
Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest (1993) 1.87
Isolation of functional subsets of human peripheral blood monocytes. J Immunol (1979) 1.52
Ras mutations in human melanoma: a marker of malignant progression. J Invest Dermatol (1994) 1.50
Mosses as biomonitors of atmospheric heavy metal deposition: spatial patterns and temporal trends in Europe. Environ Pollut (2010) 1.29
Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes. J Invest Dermatol (1996) 1.23
A serological marker for neonatal lupus erythematosus. Br J Dermatol (1982) 1.20
A potential role for superantigens in the pathogenesis of psoriasis. J Invest Dermatol (1993) 1.17
Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol (1992) 1.12
Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med (1985) 1.11
Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest (1995) 1.10
Modulation of melanocyte intercellular adhesion molecule-1 by immune cytokines. J Invest Dermatol (1990) 1.03
Trends in wound repair: cellular and molecular basis of regenerative therapy using electromagnetic fields. Curr Mol Med (2012) 1.02
Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis. J Invest Dermatol (1995) 1.01
Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm Res (1998) 0.99
Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice. J Clin Invest (1989) 0.99
Cultured human keratinocytes synthesize and secrete endothelin-1. J Invest Dermatol (1993) 0.97
Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin Exp Immunol (1999) 0.97
Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. J Invest Dermatol (1996) 0.96
The keratinocyte as a target for staphylococcal bacterial toxins. J Investig Dermatol Symp Proc (2001) 0.96
The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro. J Lab Clin Med (1977) 0.96
Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol (1998) 0.95
Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol (1988) 0.94
DOPA-negative melanocytes in the outer root sheath of human hair follicles express premelanosomal antigens but not a melanosomal antigen or the melanosome-associated glycoproteins tyrosinase, TRP-1, and TRP-2. J Invest Dermatol (1996) 0.93
Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes. J Invest Dermatol (1989) 0.92
An animal model of antibody binding in cutaneous lupus. Arthritis Rheum (1986) 0.92
Pyoderma gangrenosum. Abnormal monocyte function corrected in vitro with hydrocortisone. Arch Dermatol (1978) 0.92
Antibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol (1985) 0.92
The role of RNP, Sm, and SS-A/Ro-specific antisera from patients with lupus erythematosus in inducing antibody-dependent cellular cytotoxicity (ADCC) of targets coated with nonhistone nuclear antigens. Clin Immunol Immunopathol (1984) 0.91
Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis. J Clin Invest (1999) 0.91
Childhood pemphigus foliaceus: case report and review of the literature. Pediatr Dermatol (1986) 0.91
Immunogenetics of the neonatal lupus syndrome. Ann Intern Med (1983) 0.90
The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases. Br J Dermatol (1998) 0.89
Reversible resistance to apoptosis in cutaneous T cell lymphoma. Ann N Y Acad Sci (2001) 0.89
Overexpression of mutant ras in human melanoma increases invasiveness, proliferation and anchorage-independent growth in vitro and induces tumour formation and cachexia in vivo. Melanoma Res (1999) 0.89
Tumor necrosis factor-alpha induces interleukin-1 alpha and interleukin-1 receptor antagonist production by cultured human keratinocytes. J Invest Dermatol (1993) 0.89
Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions. J Invest Dermatol (2001) 0.89
Serum-free serial culture of adult human keratinocytes from suction-blister roof epidermis. J Invest Dermatol (1987) 0.87
Isotretinoin produces significant inhibition of monocyte and neutrophil chemotaxis in vivo in patients with cystic acne. J Invest Dermatol (1987) 0.87
Study of HLA-DR synthesis in cultured human keratinocytes. J Invest Dermatol (1986) 0.87
The role of superantigens in skin disease. J Invest Dermatol (1995) 0.87
Nitrogen concentrations in mosses indicate the spatial distribution of atmospheric nitrogen deposition in Europe. Environ Pollut (2011) 0.87
An evaluation of Brass mortality estimates under conditions of declining mortality. Demography (1978) 0.85
Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation. Curr Drug Targets (2008) 0.85
The state of differentiation of cultured human keratinocytes determines the level of intercellular adhesion molecule-1 (ICAM-1) expression induced by gamma interferon. J Invest Dermatol (1992) 0.85
Monocyte chemotaxis in leukemia patients. J Lab Clin Med (1980) 0.84
The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin. J Invest Dermatol (1985) 0.84
Human keratinocytes synthesize, secrete, and deposit fibronectin in the pericellular matrix. J Invest Dermatol (1984) 0.84
Clinical, pathological and epidemiological aspects of flood plain staggers, a corynetoxicosis of livestock grazing Agrostis avenacea. Aust Vet J (1995) 0.84
Neonatal lupus and the pathogenesis of cutaneous lupus. Pediatr Dermatol (1986) 0.83
Nevoid basal cell carcinoma syndrome. Multiple basal cell carcinomas of the palms after radiation therapy. Arch Dermatol (1980) 0.83
Defective monocyte chemotaxis in mycosis fungoides: lack of essential helper lymphocytes. Cancer (1979) 0.83
Expression of activated N-ras in a primary melanoma cell line counteracts growth inhibition by transforming growth factor-beta. J Invest Dermatol (2000) 0.82
The sequelae of group B beta-hemolytic streptococcal meningitis in early infancy. Am J Dis Child (1977) 0.82
Long-term mercury dynamics in UK soils. Environ Pollut (2011) 0.82
Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro. J Invest Dermatol (1992) 0.82
Treatment of ulcerated hemangiomas with the pulsed tunable dye laser. Am J Dis Child (1991) 0.82
Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro. J Immunol (1985) 0.81
Susceptible cytotoxicity to ultraviolet B light in fibroblasts and keratinocytes cultured from autoimmune-prone MRL/Mp-lpr/lpr mice. Clin Immunol Immunopathol (1989) 0.81
Stimulation of anti-RNP antibody binding to cultured keratinocytes by estradiol. Arch Dermatol Res (1991) 0.81
Mercury in United Kingdom topsoils; concentrations, pools, and Critical Limit exceedances. Environ Pollut (2011) 0.80
Cryoglobulinemia and decreased monocyte chemotaxis is malignant melanoma. J Invest Dermatol (1980) 0.80
Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol (1993) 0.80
In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol (1995) 0.80
Development of an in vitro keratinocyte model for use in the study of HSV specific cytotoxicity. J Invest Dermatol (1988) 0.79
Mycosis fungoides: lack of helper lymphocytes in lymphocyte-monocyte interactions [proceedings]. Br J Dermatol (1978) 0.79
Ro/SSA antigen in human epidermis. Br J Dermatol (1988) 0.79
Candida albicans induces selective expansion of human T lymphocytes expressing the T-cell receptor variable region V beta 5.1. J Dermatol Sci (1996) 0.78
Monocyte cellular function in asthmatic patients on alternate-day steroid therapy. J Allergy Clin Immunol (1978) 0.78
Neonatal lupus syndrome in successive pregnancies. J Am Acad Dermatol (1983) 0.78
Leukotriene B4-induced human melanocyte pigmentation and leukotriene C4-induced human melanocyte growth are inhibited by different isoquinolinesulfonamides. J Invest Dermatol (1992) 0.78
Effective elimination of fibroblasts in cultures of melanocytes by lowering calcium concentration in TPA depleted medium following geneticin treatment. Pigment Cell Res (1996) 0.78
Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J Invest Dermatol (1995) 0.78
Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes, and melanocytes. J Invest Dermatol (1991) 0.78
Mechanisms of cutaneous tissue damage in lupus erythematosus. Immunol Ser (1989) 0.77
Characterization and practical benefits of keratinocytes cultured in strontium-containing serum-free medium. J Invest Dermatol (1988) 0.77
Lymphocyte activation in the pathogenesis of psoriasis. J Invest Dermatol (1997) 0.77
Immunohistochemical localization of proliferating cell nuclear antigen/cyclin in human skin. Arch Dermatol Res (1992) 0.77
Cultured human melanocytes from black and white donors have different sunlight and ultraviolet A radiation sensitivities. J Invest Dermatol (1992) 0.76
Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus (1997) 0.76
Differential control of cell death in the skin. Arch Dermatol (1995) 0.75
On the treatment of hemangiomas. Pediatr Dermatol (1993) 0.75
Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma. Gene Ther (2011) 0.75
The herpes-specific immune response of individuals with herpes-associated erythema multiforme compared with that of individuals with recurrent herpes labialis. Arch Dermatol Res (1993) 0.75
Human monocyte chemotaxis: a quantitative in vivo technique. J Invest Dermatol (1979) 0.75
Dissolved inorganic nitrogen budget for a forested catchment at Beddgelert, North Wales. Environ Pollut (1993) 0.75
The therapeutic role of interferons and monoclonal antibodies in cutaneous T-cell lymphomas. J Invest Dermatol (1990) 0.75
The effect of epicutaneous glucocorticosteroids on human monocyte and neutrophil migration in vivo. J Invest Dermatol (1982) 0.75
A case report of diphtheria. Manit Med Rev (1968) 0.75
Immunologic and functional features of the leukemic cell of hairy cell leukemia: evidence for a Null hypothesis. Am J Med Sci (1980) 0.75
Reactivity of monoclonal anti-human skin basal cell antibody to cultured keratinocytes in serum-free medium. J Dermatol Sci (1990) 0.75
Positive tetracycline control of expression of p15INK4B from an Epstein-Barr autonomous plasmid in a human melanoma cell line. Gene (2000) 0.75
The pathogenesis of mycosis fungoides. Clin Exp Dermatol (1981) 0.75